(Sharecast News) - Aptamer Group announced on Tuesday that it has signed a new contract worth up to £0.62m with a top five global pharmaceutical company, marking the third collaboration between the two and further validating its 'Optimer' synthetic binder technology.
The AIM-traded biotech said the agreement would see it develop...

Email this article to a friend

or share it with one of these popular networks:

• DIGG
• FACEBOOK
• STUMBLEUPON
• MIXX
• YAHOO BUZZ
• DELICIOUS
• REDDIT
• NEWSVINE